These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 23510032
1. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis. Tan Y, Song D, Wu LH, Yu F, Zhao MH. BMC Nephrol; 2013 Mar 19; 14():63. PubMed ID: 23510032 [Abstract] [Full Text] [Related]
3. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J. Nephrol Dial Transplant; 2006 Nov 19; 21(11):3115-21. PubMed ID: 16877491 [Abstract] [Full Text] [Related]
11. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis. Tan Y, Zhou W, Yu F, Fang Q, Yang HZ, Zhao MH. Mol Immunol; 2009 Jul 19; 46(11-12):2178-82. PubMed ID: 19481805 [Abstract] [Full Text] [Related]
14. Association between anti-C1q antibodies and glomerular tuft necrosis in lupus nephritis. Jourde-Chiche N, Daniel L, Chiche L, Burtey S, Mancini J, Jego S, San Marco M, Bardin N. Clin Nephrol; 2012 Mar 19; 77(3):211-8. PubMed ID: 22377252 [Abstract] [Full Text] [Related]
15. Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis. Pang Y, Tan Y, Li Y, Zhang J, Guo Y, Guo Z, Zhang C, Yu F, Zhao MH. Kidney Int; 2016 Dec 19; 90(6):1357-1367. PubMed ID: 27745701 [Abstract] [Full Text] [Related]
16. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G. Clin Rheumatol; 2003 Oct 19; 22(4-5):271-8. PubMed ID: 14576989 [Abstract] [Full Text] [Related]
18. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro. Pang Y, Yang XW, Song Y, Yu F, Zhao MH. Immunobiology; 2014 Dec 19; 219(12):980-9. PubMed ID: 25092568 [Abstract] [Full Text] [Related]
19. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus. Meyer OC, Nicaise-Roland P, Cadoudal N, Grootenboer-Mignot S, Palazzo E, Hayem G, Dieudé P, Chollet-Martin S. Arthritis Res Ther; 2009 Dec 19; 11(3):R87. PubMed ID: 19515233 [Abstract] [Full Text] [Related]
20. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M. Lupus; 2011 Oct 19; 20(12):1267-74. PubMed ID: 21813587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]